Understanding Metastatic Breast Cancer
Understanding Metastatic Breast Cancer

Understanding Metastatic Breast Cancer

Dana Donofree
3 min read

Understanding Metastatic Breast Cancer: An In-Depth Look

Metastatic breast cancer (MBC), often referred to as stage IV breast cancer, is a complex and challenging diagnosis that profoundly impacts patients and their loved ones. In this blog, we’ll explore what metastatic breast cancer is, who it affects, relevant statistics, and the ongoing efforts to improve outcomes for those living with this condition.

What is Metastatic Breast Cancer?

Breast cancer begins in the breast tissue and can spread (metastasize) to other parts of the body, including the bones, liver, lungs, and brain. Metastatic breast cancer is the term used when cancer cells from the breast have spread to distant sites. This stage of cancer is often more difficult to treat and can lead to various symptoms that significantly affect quality of life.

Who Does It Impact?

Metastatic breast cancer can impact anyone diagnosed with breast cancer, regardless of their age, race, or socioeconomic status. However, certain factors can increase the risk of metastasis, including:

  • Age: Younger women may be more likely to experience aggressive forms of breast cancer that can metastasize.
  • Tumor Characteristics: Certain types of breast cancer, such as triple-negative or HER2-positive breast cancer, have a higher likelihood of metastasizing.
  • Genetics: Women with genetic mutations, such as BRCA1 or BRCA2, may be at an increased risk.

While breast cancer is often thought of as a women’s disease, men can also be diagnosed with breast cancer and may experience metastasis.

Statistics on Metastatic Breast Cancer

The statistics surrounding metastatic breast cancer can be stark:

  • Prevalence: Approximately 30% of women diagnosed with early-stage breast cancer will go on to develop metastatic disease.
  • Survival Rates: The five-year relative survival rate for metastatic breast cancer is around 29%, though this can vary widely based on individual factors, treatment options, and advancements in care.
  • Incidence: In the United States, over 290,000 new cases of breast cancer are expected annually, with around 6-10% being diagnosed with metastatic disease at the outset.

The Emotional and Physical Impact

A diagnosis of metastatic breast cancer can be overwhelming. Patients may experience a wide range of emotions, including fear, anger, and sadness. Physical symptoms can vary but may include pain, fatigue, and other complications depending on where the cancer has spread.

Support systems, including family, friends, and healthcare professionals, play a crucial role in helping patients navigate this journey. Many organizations provide resources, counseling, and support groups specifically tailored for those affected by metastatic breast cancer.

Advances in Treatment

The landscape of metastatic breast cancer treatment is continually evolving. While MBC is currently considered incurable, many treatment options can help manage the disease and improve quality of life. These may include:

  • Hormonal Therapy: For hormone receptor-positive cancers, treatments that block hormones can slow cancer growth.
  • Chemotherapy: Often used to target aggressive cancer cells.
  • Targeted Therapy: Drugs designed to target specific characteristics of cancer cells, such as HER2-targeted therapies.
  • Immunotherapy: A promising area of research that uses the body’s immune system to fight cancer.

Clinical trials are also essential for developing new treatments, and patients are often encouraged to consider participating in these studies.

The Path Forward

While a diagnosis of metastatic breast cancer can be daunting, it is essential to remember that research and support are advancing rapidly. Ongoing advocacy efforts aim to raise awareness, improve funding for research, and enhance access to care for patients.

Let's Raise Awareness

We just launched a collection, in honor of METAvivor, a non-profit organization that funds research and provides support for people with metastatic breast cancer (MBC). The collection includes a bomber jacket, a hat, a beanie, a drawstring bag, and a bandana. We have vowed to donate 100% of the net proceeds of this collection to METAvivor, so we can help fund more research for metastatic breast cancer. 

Conclusion

Metastatic breast cancer remains a significant health challenge, but through understanding, support, and continued research, there is hope for improved outcomes. By fostering awareness and compassion, we can help those affected by MBC navigate their journey with dignity and resilience. Whether you are a patient, a caregiver, or someone looking to support a loved one, knowledge and connection are powerful tools in this fight.

Dana Donofree
Dana Donofree

Founder and CEO of AnaOno. After a diagnosis of breast cancer in her late 20’s, Dana took her own lived experience and fashion design background and (re)designed intimates for those that have undergone breast surgery. Dana’s story has been published around the world in outlets like New York Times, BBC, Huffington Post, The Today Show, and more.